#	Pagina
attuale pagina	/open-h2020/projects/219793/index.html
-1	/open-h2020/projects/194758/index.html
-2	/open-h2020/per-topic/poder/list/index.html
-3	/open-h2020/projects/193241/deliverables.html
-4	/open-consip/fornitori/2016/profilo-08093201211/index.html
-5	/open-consip/fornitori/2015/profilo-01709160509/index.html
-6	/open-h2020/projects/198510/deliverables.html
-7	/open-h2020/per-topic/xilinx/list/index.html
-8	/open-consip/fornitori/2017/profilo-02783670272/index.html
-9	/open-h2020/projects/221926/deliverables.html
-10	/open-h2020/projects/209517/deliverables.html

Opendata, web and dolomites

NUMA-SCALE

Enabling Large-Scale GMP-ready Peptide Production with a new, reliable and cost-efficient Bioprocess

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

NUMA-SCALE project word cloud

Explore the words cloud of the NUMA-SCALE project. It provides you a very rough idea of what is the project "NUMA-SCALE" about.

economical tolerated sugar insulin jobs downstream ones seize peptide amounts facilities treating markets gained bad innovative environmentally venture numaferm business upstream 50x numaswitch length commercial efficient companies selective upscale certain tackle metabolism positive numatag creation 90 gt compliant drugs contract human german print market 2015 scalability compromises raw company material founded peptides generate ready manufacture ton pharmaceutical technologies scalable extend good approved successfully foot practices block alternatives efficacious safe manufacturing biomolecules 14 employability transfer tech relatively gmp patented carbon massive 2023 mission diseases boost numa 8m ip limitation competent efficiency revenues therapeutics escalate 15

Project "NUMA-SCALE" data sheet

The following table provides information about the project.

Coordinator	NUMAFERM GMBH Organization address address: MEROWINGERPLATZ 1A city: DUSSELDORF postcode: 40225 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Germany [DE]
Project website	https://numaferm.com/
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
Code Call	H2020-SMEInst-2018-2020-1
Funding Scheme	SME-1
Starting year	2018
Duration (year-month-day)	from 2018-11-01 to 2019-02-28

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	NUMAFERM GMBH NUMAFERM GMBH Organization address address: MEROWINGERPLATZ 1A city: DUSSELDORF postcode: 40225 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DE (DUSSELDORF)	coordinator	50˙000.00

Map

Project objective

Peptides, competent biomolecules, have gained increased interest as innovative therapeutics in the pharmaceutical market due to being highly selective, efficacious, relatively safe and well tolerated. Peptide-based drugs have been successfully applied in treating certain human diseases. Well-known example includes insulin, which compromises a peptide that is built to block and control the metabolism of sugar. With the increase of approved peptide-based drugs, the production of peptides will escalate. Yet, peptide manufacture companies (for peptide-based drugs), which need to be compliant with good manufacturing practices (GMP), face a several challenges, the main ones being high production costs on downstream processes (due to the use of high raw material amounts) and bad scalability. Numaferm is a German company founded in 2015 with the mission of making peptides economical for pharmaceutical markets. To tackle current challenges, we have developed two (patented) innovative technologies (NUMAtag and NUMAswitch) whose unique features are not offered by the alternatives in the market for peptide manufacture: cost-efficient production (50x reduction of manufacturing costs, under GMP); environmentally friendly process (reduced carbon foot print by >90%); scalable production (peptide scalability by ton scale with no peptide length limitation), thus enabling a high efficiency upstream and downstream process for peptide manufacture. Through the NUMA-SCALE project we aim to upscale our production and extend our commercial capabilities (by making our processes ready for tech-transfer into GMP facilities of Contract Manufacture Organizations) thus allowing us to seize more business opportunities. This project will have a massive positive impact to Numaferm – will boost our revenues (€14.8M by 2023), employability (creation of 15 new jobs) and generate new IP, allowing us to continuously venture new markets with our technology.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NUMA-SCALE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NUMA-SCALE" are provided by the European Opendata Portal: CORDIS opendata.